Found: 7
Select item for more details and to access through your institution.
Functionalized 1,2,3-triazolium salts as potential agents against visceral leishmaniasis.
- Published in:
- Parasitology Research, 2022, v. 121, n. 5, p. 1389, doi. 10.1007/s00436-022-07431-9
- By:
- Publication type:
- Article
Different infective forms trigger distinct lesions in the colon during experimental Chagas disease.
- Published in:
- Parasitology Research, 2021, v. 120, n. 10, p. 3475, doi. 10.1007/s00436-021-07236-2
- By:
- Publication type:
- Article
Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain.
- Published in:
- Pathogens, 2021, v. 10, n. 6, p. 729, doi. 10.3390/pathogens10060729
- By:
- Publication type:
- Article
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
- By:
- Publication type:
- Article
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
- Published in:
- Parasite (1252607X), 2020, v. 27, p. 1, doi. 10.1051/parasite/2020027
- By:
- Publication type:
- Article
Population pharmacokinetics and biodistribution of benznidazole in mice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2020, v. 75, n. 8, p. 2213, doi. 10.1093/jac/dkaa130
- By:
- Publication type:
- Article
Population pharmacokinetics and biodistribution of benznidazole in mice.
- Published in:
- 2020
- By:
- Publication type:
- journal article